Anzeige
Mehr »
Login
Mittwoch, 06.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
300% Aktienanstieg war nur der Vorgeschmack – Warum diese Kupferstory noch besser wird!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
551 Leser
Artikel bewerten:
(2)

Finsbury Growth & Income Trust Plc - Result of AGM

Finsbury Growth & Income Trust Plc - Result of AGM

PR Newswire

9 February 2022

Finsbury Growth & Income Trust PLC

(the "Company")


Result of Annual General Meeting

The Finsbury Growth & Income Trust PLC Annual General Meeting was held earlier today. All resolutions were passed.

The proxy voting figures are shown below:

ResolutionsVotes
For
%Votes Against%Total Votes CastVotes
Withheld
Ordinary Resolutions
1. To receive the Annual Report and Financial Statements for the year ended 30 September 2021. 66,109,05399.97%16,7250.03%66,125,77825,586
2. To re-elect Simon Hayes as a Director of the Company.65,377,09098.94%698,0761.06%66,075,16676,198
3. To re-elect James Aston as a Director of the Company.65,986,11599.87%87,9190.13%66,074,03477,330
4. To re-elect Kate Cornish-Bowden as a Director of the Company.66,017,37999.93%47,8570.07%66,065,23686,128
5. To re-elect Sandra Kelly as a Director of Company.66,035,94299.95%35,3310.05%66,071,27380,091
6. To re-elect Lorna Tilbian as a Director of the Company.65,963,36699.85%100,7380.15%66,064,10487,260
7. To receive and approve the Directors' Remuneration Report for year ended 30 September 2021.65,858,48799.72%182,1760.28%66,040,663110,701
8. To re-appoint PricewaterhouseCoopers LLP as Auditors to the Company, to hold office from the conclusion of this meeting until the conclusion of the next general meeting at which financial statements are laid before the Company.65,892,58899.76%160,9460.24%66,053,53497,830
9. To authorise the Audit Committee to determine the remuneration of the Auditors of the Company.66,064,14899.96%29,2420.04%66,093,39057,974
10. To receive and approve the Company's Dividend Policy, as set out in the Annual Report.66,104,39399.97%18,6510.03%66,123,04428,320
Special Business
11. To allot securities in the Company. (Ordinary Resolution)66,055,21099.94%41,7410.06%66,096,95154,413
12. To disapply the rights of pre-emption in relation to the allotment of securities. (Special Resolution)65,959,58699.80%129,0770.20%66,088,66362,701
13. To disapply pre-emption rights on the sale of Treasury Shares and to sell Treasury Shares at a premium to the net asset value per share. (Special Resolution)65,670,14399.34%439,5400.66%66,109,68341,681
14. To authorise the Company to make market purchases of Ordinary shares in the Company. (Special Resolution)66,034,27599.87%83,770 0.13%66,118,04533,319
15. That the Articles of Association set out in the Annual Report and Notice of Meeting be approved and adopted. (Special Resolution)65,521,40899.14%565,7060.86%66,087,11464,250
16. That the Directors be permitted to call General Meetings (excluding the AGM) on not less than 14 clear days' notice. (Special Resolution)65,676,83899.34%438,6640.66%66,115,50235,862

A vote Withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" and "Against" a resolution.

Notes:

Any proxy votes which are at the discretion of the Chairman have been included in the "for" total. A vote withheld is not a vote in law and is not counted in the votes for or against a resolution.

As at 12 noon on Monday, 7 February 2022, the time by which shareholders who wanted to vote at the Annual General Meeting must have been entered on the Company's register of members the total number of voting rights in the Company was 224,019,354. The Company had 971,949 ordinary shares held in Treasury.

The full text of the resolutions can be found in the Notice of Annual General Meeting, which is available for viewing at the National Storage Mechanism and can be located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website, www.finsburygt.com

In accordance with Listing Rule 9.6.2 and Listing Rule 9.6.3, the full text of the special business resolutions passed has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism. The special business resolutions will additionally be filed with Companies House.

Terms not otherwise defined in this announcement have the meaning given to them in the Notice of Meeting.

For further information, please contact:

Frostrow Capital LLP
Victoria Hale, Company Secretary
+44 (0)20 3170 8732
info@frostrow.com
© 2022 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.